# Rates and Severity of PONV for Neuromuscular Block Reversal in Patients Receiving Gastric Bypass Bariatric Surgery

> **NCT03432845** · — · WITHDRAWN · sponsor: **WellSpan Health**

## Conditions studied

- Bariatric Surgery Candidate

## Interventions

- **OTHER:** compare reversal agents

## Key facts

- **NCT ID:** NCT03432845
- **Lead sponsor:** WellSpan Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left institution
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03432845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03432845, "Rates and Severity of PONV for Neuromuscular Block Reversal in Patients Receiving Gastric Bypass Bariatric Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03432845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*